Non-Ischemic Cardiogenic Shock: A Rising Mortality Burden

For decades, the medical community has treated cardiogenic shock (CS) primarily as the catastrophic aftermath of a massive heart attack. However, new data reveals a dangerous shift in the landscape of cardiovascular mortality: while we are getting better at saving patients from heart-attack-induced shock, we are losing the battle against shock triggered by heart failure … Read more

Heart Organoids: New Hope for Atrial Fibrillation Therapy

For the first time in three decades, the landscape of atrial fibrillation (A-fib) treatment is poised for a dramatic shift. A breakthrough at Michigan State University (MSU) has yielded functional, human heart organoids capable of replicating A-fib, offering a desperately needed platform for drug development and a potential end to the stagnation in therapeutic options … Read more